U S Physical Therapy Inc income statement
In fiscal 2025, U S Physical Therapy Inc reported revenue of $781m, up 16.3% on the year before, operating income of $86.7m (a 11.1% margin) and net income of $39.6m, or $1.42 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 201 | 211 | 232 | 250 | 264 | 305 | 331 | 357 | 414 | 454 | 482 | 423 | 495 | 553 | 605 | 671 | 781 | 812 |
| Gross profit | — | 56 | 56 | 63 | 65 | 76 | 78 | 82 | 91 | 102 | 112 | 94 | 117 | 112 | 122 | 124 | 150 | 152 |
| Selling, general and administrative | — | — | — | — | 26 | 30 | 31 | 32 | 36 | 41 | 45 | 42 | 47 | 46 | 52 | 58 | 69 | 73 |
| Operating income | 28 | 33 | 31 | 38 | 39 | 46 | 47 | 50 | 55 | 60 | 67 | 52 | 71 | 57 | 51 | 63 | 87 | 77 |
| Interest expense | 0 | 0 | 0 | 1 | 1 | 7 | 7 | 11 | 21 | 2 | 2 | — | — | — | — | — | — | — |
| Income before tax | 28 | 34 | 36 | 38 | 38 | 38 | 40 | 38 | 34 | 60 | 71 | 66 | 73 | 56 | 49 | 60 | 78 | 67 |
| Income tax | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 12 | 6 | 11 | 14 | 13 | 15 | 12 | 12 | 15 | 20 | 18 |
| Net income | 12 | 16 | 21 | 18 | 13 | 19 | 21 | 21 | 22 | 35 | 40 | 35 | 41 | 32 | 28 | 31 | 40 | 32 |
| Diluted EPS | $1.00 | $1.32 | $1.75 | $1.51 | $1.05 | $1.62 | $1.77 | $1.64 | $1.76 | $1.31 | $2.45 | $2.48 | $2.41 | $2.25 | $1.28 | $1.84 | $1.42 | $2.13 |
| Diluted shares (average) | 12m | 12m | 12m | 12m | 12m | 12m | 12m | 13m | 13m | 13m | 13m | 13m | 13m | 13m | 14m | 15m | 15m | 15m |
| EBITDA | 34 | 39 | 37 | 44 | 44 | 53 | 55 | 58 | 64 | 70 | 78 | 63 | 82 | 72 | 66 | 82 | 109 | 98 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 168 | 180 | 184 | 197 | 197 | 203 | 198 | 214 |
| Gross profit | 29 | 33 | 31 | 42 | 37 | 40 | 33 | 42 |
| Selling, general and administrative | 14 | 16 | 16 | 17 | 17 | 18 | 18 | 19 |
| Operating income | 13 | 20 | 20 | 25 | 25 | 17 | 12 | 22 |
| Income before tax | 12 | 18 | 17 | 23 | 23 | 15 | 11 | 19 |
| Income tax | 3 | 6 | 4 | 5 | 5 | 6 | 2 | 4 |
| Net income | 7 | 9 | 10 | 12 | 13 | 4 | 5 | 10 |
| Diluted EPS | $0.39 | $0.52 | $0.80 | $0.58 | $0.48 | −$0.43 | −$0.12 | $0.25 |
| EBITDA | 17 | 25 | 26 | 31 | 31 | 21 | 18 | 28 |
Compare with peers
- Corvel Corp income statement
- Innovage Holding Corp. income statement
- Pennant Group, Inc. income statement
- Starling Oncology, Inc. income statement
- Guardant Health, Inc. income statement
Head to head: CRVL vs USPHINNV vs USPHPNTG vs USPHSTLN vs USPH
More: Health Care Services stocks compared, Health Care sector, rankings of US companies